Population
TMEV-susceptible SJL/J and TMEV-resistant C57BL/6 mouse strains
Comparison
TMEV infection and immunization vs Comparison between susceptible and resistant…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for VP2-targeted immunomodulation in TMEV demyelination; human studies needed before clinical adoption.
Identification of an immunodominant T cell determinant on the VP2 capsid protein in TMEV-susceptible SJL/J mice provides a potential target for specific immunoregulatory processes in demyelinating disease.
Gerety et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: